SER: the balance sheet

MyFinsight

For the year ending 2025-12-31, SER has $6,951K in assets. $6,988K in debts. $3,056K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	3,056
Prepaid expenses and other current assets	3,024
Total current assets	6,080
Property and equipment, net	465
Right of use assets - operating leases	377
Right of use assets - finance leases	0
Other long-term prepaid assets	29
Total assets	6,951

Accounts payable	1,931
Accrued expenses	1,207
Warrant liability	88
Other current liabilities	337
Total current liabilities	3,563
Warrant liability, non-current	283
Convertible note, net	2,946
Operating lease liabilities, net of current portion	196
Total liabilities	6,988
Series a convertible preferred stock, 0.0001 par value, 5,000 shares authorized 965 and zero shares issued and outstanding at december31, 2025 and 2024, respectively liquidation preference of 5,000 and zero at december31, 2025 and 2024, respectively	4,940
Common stock, 0.0001 par value, 40,000 shares authorized and 10,767 and 9,422 shares issued and outstanding at december31, 2025 and 2024, respectively (including 57 shares declared as a stock dividend on april 1, 2025 and issued on march 31, 2026)	1
Additional paid-in capital	58,536
Accumulated other comprehensive loss	-14
Accumulated deficit	-63,500
Total serina therapeutics, inc. stockholders (deficit) equity	-37
Noncontrolling deficit	0
Total stockholders' (deficit) equity	-37
Total liabilities and stockholders (deficit) equity	6,951

Unit: Thousand (K) dollars (except for numbers of shares and EPS).